PCN8 COST-EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY WITH URACIL-TEGAFUR, AN ORAL FLUOROPYRIMIDINE DERIVATIVE, IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER IN JAPAN
May 1, 2006, 00:00
10.1016/S1098-3015(10)64633-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)64633-5/fulltext
Title :
PCN8 COST-EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY WITH URACIL-TEGAFUR, AN ORAL FLUOROPYRIMIDINE DERIVATIVE, IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER IN JAPAN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64633-5&doi=10.1016/S1098-3015(10)64633-5
First page :
Section Title :
Open access? :
No
Section Order :
35